Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2005
06/30/2005US20050143368 Chemical compounds
06/30/2005US20050143354 Association of an antithrombotic and aspirin
06/30/2005US20050143346 Blocks the phosphorylation of ceramide and sphingosine, thereby maintaining high concentration of ceramide and sphingosine; has inhibitory activity of sphingosine kinase
06/30/2005US20050143315 N-[5-[[[5-[[[2-[(aminoiminomethyl)amino]ethyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[(2-bromo-1-oxo-2-propenyl)amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide hydrochloride having radiosensitisation activity
06/30/2005US20050143308 Survivin, a protein that inhibits cellular apoptosis, and its modulation
06/30/2005US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein)
06/30/2005US20050142640 MUC-1 derived peptides
06/30/2005US20050142628 Use
06/30/2005US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis
06/30/2005US20050142566 Sperm-specific cation channel, catSper2, and uses therefor
06/30/2005US20050142191 Pharmaceutical formulations of amyloid inhibiting compounds
06/30/2005US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
06/30/2005US20050142120 Cells expressing anti-Fc receptor binding components
06/30/2005US20050142118 Human cord blood derived unrestricted somatic stem cells (USSC)
06/30/2005US20050142100 Tumor Necrosis Factor Binding Protein (TBP) or an isoform, mutein, fused protein, function derivative, active fraction, or salt; multiple sclerosis; corticosteroid; glatiramer
06/30/2005US20050142088 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
06/30/2005US20050142081 Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least on matrix metalloproteinase inhibitor
06/30/2005US20050142072 Drug delivery into nose; controlling concentration into blood; using opioid or non-steroil antiinflammatory dryg
06/30/2005US20050142065 Administering test compound to a diabetes mellitus model non-human mammal such as a rat; selecting compound that causes a decrease in a glycated hemoglobin value after administration; drug screening
06/30/2005US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction
06/30/2005CA2556342A1 Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor
06/30/2005CA2549878A1 Glycosylation-deficient hepatocyte growth factor
06/30/2005CA2548790A1 Medicinal compositions and combinations
06/30/2005CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/30/2005CA2547820A1 (s)-2-n-propylamino-5-hydroxytetralin as a d3 agonist
06/29/2005EP1548435A1 Diagnostic and examination method for eating disorder
06/29/2005EP1548121A1 Novel physiologically active substances
06/29/2005EP1548118A2 Complementary adenoviral vector systems and cell lines
06/29/2005EP1548024A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/29/2005EP1548015A1 Novel crystals
06/29/2005EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same
06/29/2005EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
06/29/2005EP1547617A1 Arthrodial cartilage extracellular matrix degradation inhibitor
06/29/2005EP1547616A1 Preventive and/or therapeutic drugs for itch
06/29/2005EP1547615A1 Remedy
06/29/2005EP1547614A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
06/29/2005EP1547608A1 Remedy
06/29/2005EP1547606A1 Method of preparing platelet rich plasma
06/29/2005EP1547604A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
06/29/2005EP1547600A1 Female hormone-containing patch
06/29/2005EP1547595A1 Patch for transdermal administration
06/29/2005EP1547594A1 Preventive or remedy for bedsore
06/29/2005EP1547591A1 Food improving blood flow
06/29/2005EP1547587A1 Agent for reducing side effects of diclofenac
06/29/2005EP1547586A1 Hypogastric and/or perineal pain-relieving agent
06/29/2005EP1547584A1 Particulate product comprising pantethine
06/29/2005EP1547577A1 Antiaging composition
06/29/2005EP1546704A2 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
06/29/2005EP1546703A2 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
06/29/2005EP1546401A1 OLIGONUCLEOTIDE TAGGED NUCLEOSIDE TRIPHOSPHATES (OTNTPs) FOR GENETIC ANALYSIS
06/29/2005EP1546173A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna
06/29/2005EP1546153A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
06/29/2005EP1546136A1 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
06/29/2005EP1546105A1 Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
06/29/2005EP1546086A2 Aminoalcohol derivatives
06/29/2005EP1546084A1 2,4-dihydroxybenzoic acid derivatives
06/29/2005EP1545710A2 Therapeutic use
06/29/2005EP1545619A2 Solution for ungual application
06/29/2005EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
06/29/2005EP1545554A1 Methods and compositions for treating diabetes mellitis
06/29/2005EP1545552A1 Combination therapy wherein a serotonin reuptake inhibitor is used
06/29/2005EP1545548A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
06/29/2005EP1545528A2 Indole-type derivatives as inhibitors of p38 kinase
06/29/2005EP1545527A1 Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
06/29/2005EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
06/29/2005EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics
06/29/2005EP1395550B1 Cycloalkenylsulfonamide derivatives
06/29/2005EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1272507B1 Integrin binding peptide derivatives
06/29/2005EP1246624B1 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
06/29/2005EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
06/29/2005EP1184037B1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
06/29/2005EP1165077B1 Viral treatment
06/29/2005EP1025216B1 Transgenic animal models for cardiac hypertrophy and uses thereof
06/29/2005EP0735888B1 Purine compositions
06/29/2005EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof
06/29/2005CN1633506A Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
06/29/2005CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof
06/29/2005CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
06/29/2005CN1633444A 6-11 bicyclic ketolide derivatives
06/29/2005CN1633439A Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
06/29/2005CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/29/2005CN1633436A Pyrrolopyrimidine derivatives
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors
06/29/2005CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors
06/29/2005CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
06/29/2005CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/29/2005CN1633309A Method of radio-labelling biomolecules
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 1564